351 related articles for article (PubMed ID: 9627714)
21. Tumor lymphangiogenesis: a novel prognostic indicator for cutaneous melanoma metastasis and survival.
Dadras SS; Paul T; Bertoncini J; Brown LF; Muzikansky A; Jackson DG; Ellwanger U; Garbe C; Mihm MC; Detmar M
Am J Pathol; 2003 Jun; 162(6):1951-60. PubMed ID: 12759251
[TBL] [Abstract][Full Text] [Related]
22. Expression of AP-2alpha, c-kit, and cleaved caspase-6 and -3 in naevi and malignant melanomas of the skin. A possible role for caspases in melanoma progression?
Woenckhaus C; Giebel J; Failing K; Fenic I; Dittberner T; Poetsch M
J Pathol; 2003 Oct; 201(2):278-87. PubMed ID: 14517845
[TBL] [Abstract][Full Text] [Related]
23. Angiogenesis and malignant melanoma. Angiogenesis is related to the development of vertical (tumorigenic) growth phase.
Marcoval J; Moreno A; Graells J; Vidal A; Escribà JM; Garcia-Ramírez M; Fabra A
J Cutan Pathol; 1997 Apr; 24(4):212-8. PubMed ID: 9138111
[TBL] [Abstract][Full Text] [Related]
24. Fully humanized neutralizing antibodies to interleukin-8 (ABX-IL8) inhibit angiogenesis, tumor growth, and metastasis of human melanoma.
Huang S; Mills L; Mian B; Tellez C; McCarty M; Yang XD; Gudas JM; Bar-Eli M
Am J Pathol; 2002 Jul; 161(1):125-34. PubMed ID: 12107097
[TBL] [Abstract][Full Text] [Related]
25. Vasculogenic mimicry and tumor angiogenesis.
Folberg R; Hendrix MJ; Maniotis AJ
Am J Pathol; 2000 Feb; 156(2):361-81. PubMed ID: 10666364
[TBL] [Abstract][Full Text] [Related]
26. Fibroblast cell interactions with human melanoma cells affect tumor cell growth as a function of tumor progression.
Cornil I; Theodorescu D; Man S; Herlyn M; Jambrosic J; Kerbel RS
Proc Natl Acad Sci U S A; 1991 Jul; 88(14):6028-32. PubMed ID: 2068080
[TBL] [Abstract][Full Text] [Related]
27. TIA-1 positive tumor-infiltrating lymphocytes in nevi and melanomas.
Lyle S; Salhany KE; Elder DE
Mod Pathol; 2000 Jan; 13(1):52-5. PubMed ID: 10658910
[TBL] [Abstract][Full Text] [Related]
28. Prognostic value of tumor infiltrating lymphocytes in the vertical growth phase of primary cutaneous melanoma.
Clemente CG; Mihm MC; Bufalino R; Zurrida S; Collini P; Cascinelli N
Cancer; 1996 Apr; 77(7):1303-10. PubMed ID: 8608507
[TBL] [Abstract][Full Text] [Related]
29. Progressive loss of sensitivity to endothelium-derived growth inhibitors expressed by human melanoma cells during disease progression.
Rak JW; Hegmann EJ; Lu C; Kerbel RS
J Cell Physiol; 1994 May; 159(2):245-55. PubMed ID: 8163565
[TBL] [Abstract][Full Text] [Related]
30. Relationship of tumorigenic malignant melanomas to dermal elastin: an expression of tumor/stromal interaction that may be related to prognosis.
Feinmesser M; Schachter JM; Tobar A; Sulkes J; Gutman H; Kruk N; Okon E
Am J Dermatopathol; 2002 Apr; 24(2):108-17. PubMed ID: 11979070
[TBL] [Abstract][Full Text] [Related]
31. The vascularity of primary cutaneous melanoma.
Fallowfield ME; Cook MG
J Pathol; 1991 Jul; 164(3):241-4. PubMed ID: 1890549
[TBL] [Abstract][Full Text] [Related]
32. Endogenous interleukin 6 can function as an in vivo growth- stimulatory factor for advanced-stage human melanoma cells.
Lu C; Sheehan C; Rak JW; Chambers CA; Hozumi N; Kerbel RS
Clin Cancer Res; 1996 Aug; 2(8):1417-25. PubMed ID: 9816316
[TBL] [Abstract][Full Text] [Related]
33. Cytokines, growth factors and the loss of negative growth controls in the progression of human cutaneous malignant melanoma.
Lu C; Kerbel RS
Curr Opin Oncol; 1994 Mar; 6(2):212-20. PubMed ID: 8011699
[TBL] [Abstract][Full Text] [Related]
34. CD40 is a prognostic marker in primary cutaneous malignant melanoma.
van den Oord JJ; Maes A; Stas M; Nuyts J; Battocchio S; Kasran A; Garmyn M; De Wever I; De Wolf-Peeters C
Am J Pathol; 1996 Dec; 149(6):1953-61. PubMed ID: 8952530
[TBL] [Abstract][Full Text] [Related]
35. Regional growth of different human melanomas as metastases in the brain of nude mice.
Schackert G; Price JE; Zhang RD; Bucana CD; Itoh K; Fidler IJ
Am J Pathol; 1990 Jan; 136(1):95-102. PubMed ID: 2297053
[TBL] [Abstract][Full Text] [Related]
36. Enforced c-KIT expression renders highly metastatic human melanoma cells susceptible to stem cell factor-induced apoptosis and inhibits their tumorigenic and metastatic potential.
Huang S; Luca M; Gutman M; McConkey DJ; Langley KE; Lyman SD; Bar-Eli M
Oncogene; 1996 Dec; 13(11):2339-47. PubMed ID: 8957075
[TBL] [Abstract][Full Text] [Related]
37. Angiogenesis in cutaneous malignant melanoma and potential therapeutic strategies.
Basu B; Biswas S; Wrigley J; Sirohi B; Corrie P
Expert Rev Anticancer Ther; 2009 Nov; 9(11):1583-98. PubMed ID: 19895243
[TBL] [Abstract][Full Text] [Related]
38. Tumor progression, early diagnosis and prognosis of melanoma.
Elder D
Acta Oncol; 1999; 38(5):535-47. PubMed ID: 10427941
[TBL] [Abstract][Full Text] [Related]
39. A new Mr 55,000 surface protein implicated in melanoma progression: association with a metastatic phenotype.
Boukerche H; Baril P; Tabone E; Bérard F; Sanhadji K; Balme B; Wolf F; Perrot H; Thomas L
Cancer Res; 2000 Oct; 60(20):5848-56. PubMed ID: 11059782
[TBL] [Abstract][Full Text] [Related]
40. The significance of blood flow in cutaneous malignant melanoma demonstrated by Doppler flowmetry.
Srivastava A; Hughes LE; Woodcock JP; Shedden EJ
Eur J Surg Oncol; 1986 Mar; 12(1):13-8. PubMed ID: 2420648
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
